speb/financial-data huggingface dataset:
SKIN income_statement (quarterly, 2025-09-30) — Net Income: -11031000.00
SKIN income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -11031000.00
SKIN income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -11031000.00
SKIN income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -11031000.00
SKIN income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -11031000.00
SKIN cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -11031000.00
SKIN income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -11031000.00
SKIN cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -1057000.00
SKIN income_statement (quarterly, 2025-09-30) — Net Interest Income: -5055000.00
SKIN cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -616000.00
SKIN cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -616000.00
SKIN income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -5055000.00
SKIN cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -187000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Net PPE: 16665000.00
SKIN cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -27000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -98818000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 985000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 112000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 985000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 112000.00
SKIN income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 4048000.00
SKIN income_statement (quarterly, 2025-09-30) — Normalized Income: -11071290.00
SKIN cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 9647000.00
SKIN cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -210000.00
SKIN income_statement (quarterly, 2025-09-30) — Operating Income: -6242000.00
SKIN income_statement (quarterly, 2025-09-30) — Operating Revenue: 70655000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 127301264.00
SKIN balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 7432000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -1775000.00
SKIN income_statement (quarterly, 2025-09-30) — Other Gand A: 29250000.00
SKIN income_statement (quarterly, 2025-09-30) — Other Income Expense: 652000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 37981000.00
SKIN cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 2300000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 13141000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 1882000.00
SKIN income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 601000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Other Properties: 14344000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Payables: 34342000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 54395000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 1934000.00
SKIN income_statement (quarterly, 2025-09-30) — Pretax Income: -10645000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
SKIN cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 356000.00
SKIN cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -1057000.00
SKIN cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -27000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Raw Materials: 23001000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Receivables: 25392000.00
SKIN income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 25021000.00
SKIN income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 8433000.00
SKIN cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 0.00
SKIN income_statement (quarterly, 2025-09-30) — Research And Development: 1698000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -509380000.00
SKIN income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 20928000.00
SKIN income_statement (quarterly, 2025-09-30) — Selling General And Administration: 50178000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Share Issued: 127301264.00
SKIN cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 2455000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 65660000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -98818000.00
SKIN income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 10710.00
SKIN income_statement (quarterly, 2025-09-30) — Tax Provision: 386000.00
SKIN income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
SKIN balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 3186000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Total Assets: 503636000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 429048000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Total Debt: 378980000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 65660000.00
SKIN income_statement (quarterly, 2025-09-30) — Total Expenses: 76897000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 437976000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 195269000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 376072000.00
SKIN income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -6242000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 17048000.00
SKIN income_statement (quarterly, 2025-09-30) — Total Unusual Items: 51000.00
SKIN income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 51000.00
SKIN balance_sheet (quarterly, 2025-09-30) — Working Capital: 246463000.00
SKIN income_statement (annual, 2025-12-31) — +Operating Expense: 217167000.00
SKIN income_statement (quarterly, 2025-12-31) — +Operating Expense: 52876000.00
SKIN income_statement (annual, 2025-12-31) — +Total Revenue: 300790000.00
SKIN income_statement (quarterly, 2025-12-31) — +Total Revenue: 82368000.00
SKIN balance_sheet (annual, 2025-12-31) — Accounts Payable: 15631000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 15631000.00
SKIN balance_sheet (annual, 2025-12-31) — Accounts Receivable: 21741000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 21741000.00
SKIN balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -22798000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -22798000.00
SKIN balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 579961000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 579961000.00
SKIN balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -6022000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -6022000.00
SKIN cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 21501000.00
SKIN cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 4707000.00
SKIN cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 21501000.00
SKIN cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 4707000.00
SKIN cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 7219000.00
SKIN cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 3576000.00
SKIN income_statement (annual, 2025-12-31) — Average Dilution Earnings: -12590000.00
SKIN income_statement (quarterly, 2025-12-31) — Average Dilution Earnings: 527000.00
SKIN income_statement (annual, 2025-12-31) — Basic Average Shares: 126378509.00
SKIN income_statement (quarterly, 2025-12-31) — Basic Average Shares: 127439511.00
SKIN income_statement (annual, 2025-12-31) — Basic EPS: -0.08
SKIN income_statement (quarterly, 2025-12-31) — Basic EPS: -0.06
SKIN cash_flow (annual, 2025-12-31) — Beginning Cash Position: 370063000.00
SKIN cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 219397000.00
SKIN cash_flow (annual, 2025-12-31) — Capital Expenditure: -5163000.00
SKIN cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1382000.00
SKIN balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 14366000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 14366000.00
SKIN balance_sheet (annual, 2025-12-31) — Capital Stock: 13000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Capital Stock: 13000.00
SKIN balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 232673000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 232673000.00
SKIN balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 232673000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 232673000.00
SKIN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -174926000.00
SKIN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -512000.00
SKIN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -5163000.00
SKIN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1382000.00
SKIN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 37485000.00
SKIN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 15196000.00
SKIN cash_flow (annual, 2025-12-31) — Change In Inventory: 15792000.00
SKIN cash_flow (quarterly, 2025-12-31) — Change In Inventory: 4678000.00
SKIN cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -6825000.00
SKIN cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -663000.00
SKIN cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -7179000.00
SKIN cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -62000.00
SKIN cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 3423000.00
SKIN cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 3533000.00
SKIN cash_flow (annual, 2025-12-31) — Change In Receivables: 5162000.00
SKIN cash_flow (quarterly, 2025-12-31) — Change In Receivables: 393000.00
SKIN cash_flow (annual, 2025-12-31) — Change In Working Capital: 10373000.00
SKIN cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 7879000.00
SKIN cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 5162000.00
SKIN cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 393000.00
SKIN cash_flow (annual, 2025-12-31) — Changes In Cash: -142604000.00
SKIN cash_flow (quarterly, 2025-12-31) — Changes In Cash: 13302000.00
SKIN balance_sheet (annual, 2025-12-31) — Common Stock: 13000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Common Stock: 13000.00
SKIN balance_sheet (annual, 2025-12-31) — Common Stock Equity: 61056000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 61056000.00
SKIN cash_flow (annual, 2025-12-31) — Common Stock Payments: 0.00
SKIN balance_sheet (annual, 2025-12-31) — Construction In Progress: 55000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 55000.00
SKIN income_statement (annual, 2025-12-31) — Cost Of Revenue: 104426000.00
SKIN income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 29330000.00
SKIN balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 15592000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 15592000.00
SKIN balance_sheet (annual, 2025-12-31) — Current Assets: 309517000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Current Assets: 309517000.00
SKIN balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 5128000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 5128000.00
SKIN balance_sheet (annual, 2025-12-31) — Current Debt: 123959000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Current Debt: 123959000.00
SKIN balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 129087000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 129087000.00
SKIN balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 1012000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 1012000.00
SKIN balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 1012000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 1012000.00
SKIN balance_sheet (annual, 2025-12-31) — Current Liabilities: 186275000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 186275000.00
SKIN cash_flow (annual, 2025-12-31) — Deferred Income Tax: 2219000.00
SKIN cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -674000.00
SKIN cash_flow (annual, 2025-12-31) — Deferred Tax: 2219000.00
SKIN cash_flow (quarterly, 2025-12-31) — Deferred Tax: -674000.00
SKIN cash_flow (annual, 2025-12-31) — Depreciation: 3848000.00
SKIN cash_flow (quarterly, 2025-12-31) — Depreciation: 644000.00
SKIN cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 25349000.00
SKIN cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 5351000.00
SKIN cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 25349000.00
SKIN cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 5351000.00
SKIN income_statement (annual, 2025-12-31) — Diluted Average Shares: 135798202.00
SKIN income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 127439511.00
SKIN income_statement (annual, 2025-12-31) — Diluted EPS: -0.16
SKIN income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.06
SKIN income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -22109000.00
SKIN income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -7577000.00
SKIN income_statement (annual, 2025-12-31) — EBIT: 13388000.00
SKIN income_statement (quarterly, 2025-12-31) — EBIT: 1565000.00
SKIN income_statement (annual, 2025-12-31) — EBITDA: 38737000.00
SKIN income_statement (quarterly, 2025-12-31) — EBITDA: 6916000.00
SKIN cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 5214000.00
SKIN cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -26000.00
SKIN cash_flow (annual, 2025-12-31) — End Cash Position: 232673000.00
SKIN cash_flow (quarterly, 2025-12-31) — End Cash Position: 232673000.00
SKIN cash_flow (annual, 2025-12-31) — Financing Cash Flow: -174926000.00
SKIN cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -512000.00
SKIN balance_sheet (annual, 2025-12-31) — Finished Goods: 29466000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Finished Goods: 29466000.00
SKIN cash_flow (annual, 2025-12-31) — Free Cash Flow: 32322000.00
SKIN cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 13814000.00
SKIN cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -487000.00
SKIN cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -138000.00
SKIN income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 6306000.00
SKIN income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -233000.00
SKIN balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -1434000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -1434000.00
SKIN income_statement (annual, 2025-12-31) — General And Administrative Expense: 117949000.00
SKIN income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 27682000.00
SKIN balance_sheet (annual, 2025-12-31) — Goodwill: 126621000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Goodwill: 126621000.00
SKIN balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 162384000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 162384000.00
SKIN balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 27763000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 27763000.00
SKIN balance_sheet (annual, 2025-12-31) — Gross PPE: 36906000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Gross PPE: 36906000.00
SKIN income_statement (annual, 2025-12-31) — Gross Profit: 196364000.00
SKIN income_statement (quarterly, 2025-12-31) — Gross Profit: 53038000.00
SKIN balance_sheet (annual, 2025-12-31) — Income Tax Payable: 1226000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 1226000.00
SKIN income_statement (annual, 2025-12-31) — Interest Expense: 19326000.00
SKIN income_statement (quarterly, 2025-12-31) — Interest Expense: 6373000.00
SKIN income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 19326000.00
SKIN income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 6373000.00
SKIN income_statement (annual, 2025-12-31) — Interest Income: 8954000.00
SKIN income_statement (quarterly, 2025-12-31) — Interest Income: 1512000.00
SKIN income_statement (annual, 2025-12-31) — Interest Income Non Operating: 8954000.00
SKIN income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 1512000.00
SKIN cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 14440000.00
SKIN balance_sheet (annual, 2025-12-31) — Interest Payable: 2929000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Interest Payable: 2929000.00
SKIN balance_sheet (annual, 2025-12-31) — Inventory: 48012000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Inventory: 48012000.00
SKIN balance_sheet (annual, 2025-12-31) — Invested Capital: 425446000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Invested Capital: 425446000.00
SKIN cash_flow (annual, 2025-12-31) — Investing Cash Flow: -5163000.00
SKIN cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -1382000.00
SKIN cash_flow (annual, 2025-12-31) — Issuance Of Debt: 237601000.00
SKIN cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: -85000.00
SKIN balance_sheet (annual, 2025-12-31) — Leases: 11080000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Leases: 11080000.00
SKIN balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 9238000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 9238000.00
SKIN balance_sheet (annual, 2025-12-31) — Long Term Debt: 240431000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 240431000.00
SKIN balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 249669000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 249669000.00
SKIN cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 237601000.00
SKIN cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: -85000.00
SKIN cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -410955000.00
SKIN cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 0.00
SKIN balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 13660000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 13660000.00
SKIN cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
SKIN balance_sheet (annual, 2025-12-31) — Net Debt: 131717000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Net Debt: 131717000.00
SKIN income_statement (annual, 2025-12-31) — Net Income: -9519000.00
SKIN income_statement (quarterly, 2025-12-31) — Net Income: -8104000.00
SKIN income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -9519000.00
SKIN income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -8104000.00
SKIN income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -9519000.00
SKIN income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -8104000.00
SKIN income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -9519000.00
SKIN income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -8104000.00
SKIN income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -9519000.00
SKIN income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -8104000.00
SKIN cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -9519000.00
SKIN cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -8104000.00
SKIN income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -9519000.00
SKIN income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -8104000.00
SKIN cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -4860000.00
SKIN cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -1243000.00
SKIN income_statement (annual, 2025-12-31) — Net Interest Income: -10372000.00
SKIN income_statement (quarterly, 2025-12-31) — Net Interest Income: -4861000.00
SKIN cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -173354000.00
SKIN cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -85000.00
SKIN cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -173354000.00
SKIN cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -85000.00
SKIN income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -10372000.00
SKIN income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -4861000.00
SKIN cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -1572000.00
SKIN cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -427000.00
SKIN balance_sheet (annual, 2025-12-31) — Net PPE: 14108000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Net PPE: 14108000.00
SKIN cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -303000.00
SKIN cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -139000.00
SKIN balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -101328000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -101328000.00
SKIN balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 1925000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 1925000.00
SKIN balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 393000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 393000.00
SKIN balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 1925000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 1925000.00
SKIN balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 393000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 393000.00
SKIN income_statement (annual, 2025-12-31) — Normalized EBITDA: 32431000.00
SKIN income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 7149000.00
SKIN income_statement (annual, 2025-12-31) — Normalized Income: -14500740.00
SKIN income_statement (quarterly, 2025-12-31) — Normalized Income: -7919930.00
SKIN cash_flow (annual, 2025-12-31) — Operating Cash Flow: 37485000.00
SKIN cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 15196000.00
SKIN cash_flow (annual, 2025-12-31) — Operating Gains Losses: -487000.00
SKIN cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -138000.00
SKIN income_statement (annual, 2025-12-31) — Operating Income: -20803000.00
SKIN income_statement (quarterly, 2025-12-31) — Operating Income: 162000.00
SKIN income_statement (annual, 2025-12-31) — Operating Revenue: 300790000.00
SKIN income_statement (quarterly, 2025-12-31) — Operating Revenue: 82368000.00
SKIN balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 127520823.00
SKIN balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 127520823.00
SKIN balance_sheet (annual, 2025-12-31) — Other Current Assets: 5395000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 5395000.00
SKIN balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 123959000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 123959000.00
SKIN balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -1434000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -1434000.00
SKIN income_statement (annual, 2025-12-31) — Other Gand A: 117949000.00
SKIN income_statement (quarterly, 2025-12-31) — Other Gand A: 27682000.00
SKIN income_statement (annual, 2025-12-31) — Other Income Expense: 25237000.00
SKIN income_statement (quarterly, 2025-12-31) — Other Income Expense: -109000.00
SKIN balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 35763000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 35763000.00
SKIN cash_flow (annual, 2025-12-31) — Other Non Cash Items: -14560000.00
SKIN cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 3587000.00
SKIN balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 11869000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 11869000.00
SKIN balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 2410000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 2410000.00
SKIN income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 18931000.00
SKIN income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 124000.00
SKIN balance_sheet (annual, 2025-12-31) — Other Properties: 12111000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Other Properties: 12111000.00
SKIN balance_sheet (annual, 2025-12-31) — Payables: 38333000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Payables: 38333000.00
SKIN balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 53925000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 53925000.00
SKIN balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2251000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2251000.00
SKIN income_statement (annual, 2025-12-31) — Pretax Income: -5938000.00
SKIN income_statement (quarterly, 2025-12-31) — Pretax Income: -4808000.00
SKIN balance_sheet (annual, 2025-12-31) — Properties: 0.00
SKIN balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
SKIN cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 2067000.00
SKIN cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 134000.00
SKIN cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -4860000.00
SKIN cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -1243000.00
SKIN cash_flow (annual, 2025-12-31) — Purchase Of PPE: -303000.00
SKIN cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -139000.00
SKIN balance_sheet (annual, 2025-12-31) — Raw Materials: 18546000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Raw Materials: 18546000.00
SKIN balance_sheet (annual, 2025-12-31) — Receivables: 23437000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Receivables: 23437000.00
SKIN income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 104426000.00
SKIN income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 29330000.00
SKIN income_statement (annual, 2025-12-31) — Reconciled Depreciation: 25349000.00
SKIN income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 5351000.00
SKIN cash_flow (annual, 2025-12-31) — Repayment Of Debt: -410955000.00
SKIN cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 0.00
SKIN cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: 0.00
SKIN income_statement (annual, 2025-12-31) — Research And Development: 5628000.00
SKIN income_statement (quarterly, 2025-12-31) — Research And Development: 1681000.00
SKIN balance_sheet (annual, 2025-12-31) — Retained Earnings: -517484000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -517484000.00
SKIN income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 93590000.00
SKIN income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 23513000.00
SKIN income_statement (annual, 2025-12-31) — Selling General And Administration: 211539000.00
SKIN income_statement (quarterly, 2025-12-31) — Selling General And Administration: 51195000.00
SKIN balance_sheet (annual, 2025-12-31) — Share Issued: 127520823.00
SKIN balance_sheet (quarterly, 2025-12-31) — Share Issued: 127520823.00
SKIN cash_flow (annual, 2025-12-31) — Stock Based Compensation: 14824000.00
SKIN cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 3585000.00
SKIN balance_sheet (annual, 2025-12-31) — Stockholders Equity: 61056000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 61056000.00
SKIN balance_sheet (annual, 2025-12-31) — Tangible Book Value: -101328000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -101328000.00
SKIN income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 1324260.00
SKIN income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -48930.00
SKIN income_statement (annual, 2025-12-31) — Tax Provision: 3581000.00
SKIN income_statement (quarterly, 2025-12-31) — Tax Provision: 3296000.00
SKIN income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
SKIN income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
SKIN balance_sheet (annual, 2025-12-31) — Taxes Receivable: 1696000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 1696000.00
SKIN balance_sheet (annual, 2025-12-31) — Total Assets: 499803000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Total Assets: 499803000.00
SKIN balance_sheet (annual, 2025-12-31) — Total Capitalization: 301487000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 301487000.00
SKIN balance_sheet (annual, 2025-12-31) — Total Debt: 378756000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Total Debt: 378756000.00
SKIN balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 61056000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 61056000.00
SKIN income_statement (annual, 2025-12-31) — Total Expenses: 321593000.00
SKIN income_statement (quarterly, 2025-12-31) — Total Expenses: 82206000.00
SKIN balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 438747000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 438747000.00
SKIN balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 190286000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 190286000.00
SKIN balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 252472000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 252472000.00
SKIN income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -20803000.00
SKIN income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 162000.00
SKIN balance_sheet (annual, 2025-12-31) — Total Tax Payable: 22702000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 22702000.00
SKIN income_statement (annual, 2025-12-31) — Total Unusual Items: 6306000.00
SKIN income_statement (quarterly, 2025-12-31) — Total Unusual Items: -233000.00
SKIN income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 6306000.00
SKIN income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -233000.00
SKIN balance_sheet (annual, 2025-12-31) — Working Capital: 123242000.00
SKIN balance_sheet (quarterly, 2025-12-31) — Working Capital: 123242000.00
SKIN income_statement (quarterly, 2026-03-31) — +Operating Expense: 46240000.00
SKIN income_statement (quarterly, 2026-03-31) — +Total Revenue: 64910000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 15885000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 18615000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -23131000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 581053000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -4988000.00
SKIN cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 4773000.00
SKIN cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 4773000.00
SKIN cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 376000.00
SKIN income_statement (quarterly, 2026-03-31) — Average Dilution Earnings: -491000.00
SKIN income_statement (quarterly, 2026-03-31) — Basic Average Shares: 127792611.00
SKIN income_statement (quarterly, 2026-03-31) — Basic EPS: -0.05
SKIN cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 232673000.00
SKIN cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -1649000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 22909000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Capital Stock: 13000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 204358000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 204358000.00
SKIN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -20906000.00
SKIN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -1649000.00
SKIN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -5554000.00
SKIN cash_flow (quarterly, 2026-03-31) — Change In Inventory: -136000.00
SKIN cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -1962000.00
SKIN cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -9558000.00
SKIN cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 28000.00
SKIN cash_flow (quarterly, 2026-03-31) — Change In Receivables: 2491000.00
SKIN cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -9137000.00
SKIN cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 2491000.00
SKIN cash_flow (quarterly, 2026-03-31) — Changes In Cash: -28109000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Common Stock: 13000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 55240000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 261000.00
SKIN income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 20471000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 17938000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Current Assets: 277695000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 4158000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Current Debt: 102944000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 107102000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 1101000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 1101000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 155202000.00
SKIN cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -515000.00
SKIN cash_flow (quarterly, 2026-03-31) — Deferred Tax: -515000.00
SKIN cash_flow (quarterly, 2026-03-31) — Depreciation: 563000.00
SKIN cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 5336000.00
SKIN cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 5336000.00
SKIN income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 131399898.00
SKIN income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.05
SKIN income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -7121000.00
SKIN income_statement (quarterly, 2026-03-31) — EBIT: -468000.00
SKIN income_statement (quarterly, 2026-03-31) — EBITDA: 4868000.00
SKIN cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -206000.00
SKIN cash_flow (quarterly, 2026-03-31) — End Cash Position: 204358000.00
SKIN cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -20906000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Finished Goods: 28062000.00
SKIN cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -7203000.00
SKIN income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -1196000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -1712000.00
SKIN income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 21943000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Goodwill: 126246000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 159044000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 23603000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Gross PPE: 45760000.00
SKIN income_statement (quarterly, 2026-03-31) — Gross Profit: 44439000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 462000.00
SKIN income_statement (quarterly, 2026-03-31) — Interest Expense: 6346000.00
SKIN income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 6346000.00
SKIN income_statement (quarterly, 2026-03-31) — Interest Income: 1485000.00
SKIN income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 1485000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Interest Payable: 7508000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Inventory: 47693000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Invested Capital: 399460000.00
SKIN cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -1649000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Leases: 11035000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 18751000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 241276000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 260027000.00
SKIN cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -20161000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 13630000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Net Debt: 139862000.00
SKIN income_statement (quarterly, 2026-03-31) — Net Income: -6630000.00
SKIN income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -6630000.00
SKIN income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -6630000.00
SKIN income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -6630000.00
SKIN income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -6630000.00
SKIN cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -6630000.00
SKIN income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -6630000.00
SKIN cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -1425000.00
SKIN income_statement (quarterly, 2026-03-31) — Net Interest Income: -4861000.00
SKIN cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -20161000.00
SKIN cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -20161000.00
SKIN income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -4861000.00
SKIN cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -745000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Net PPE: 22629000.00
SKIN cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -224000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -103804000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 2413000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 393000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 2413000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 393000.00
SKIN income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 6064000.00
SKIN income_statement (quarterly, 2026-03-31) — Normalized Income: -5466295.86
SKIN cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -5554000.00
SKIN income_statement (quarterly, 2026-03-31) — Operating Income: -1801000.00
SKIN income_statement (quarterly, 2026-03-31) — Operating Revenue: 64910000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 129144801.00
SKIN balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 5391000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 102944000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -1712000.00
SKIN income_statement (quarterly, 2026-03-31) — Other Gand A: 21943000.00
SKIN income_statement (quarterly, 2026-03-31) — Other Income Expense: -152000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 32798000.00
SKIN cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 2397000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 11452000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 2371000.00
SKIN income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 1044000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Other Properties: 20834000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Payables: 26832000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 44770000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 2229000.00
SKIN income_statement (quarterly, 2026-03-31) — Pretax Income: -6814000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
SKIN cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 540000.00
SKIN cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -1425000.00
SKIN cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -224000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Raw Materials: 19631000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Receivables: 20253000.00
SKIN income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 20471000.00
SKIN income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 5336000.00
SKIN cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -20161000.00
SKIN income_statement (quarterly, 2026-03-31) — Research And Development: 1102000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -524114000.00
SKIN income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 23195000.00
SKIN income_statement (quarterly, 2026-03-31) — Selling General And Administration: 45138000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Share Issued: 129144801.00
SKIN cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 2079000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 55240000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -103804000.00
SKIN income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -32295.86
SKIN income_statement (quarterly, 2026-03-31) — Tax Provision: -184000.00
SKIN income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.03
SKIN balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 1638000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Total Assets: 473233000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 296516000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Total Debt: 367129000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 55240000.00
SKIN income_statement (quarterly, 2026-03-31) — Total Expenses: 66711000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 417993000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 195538000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 262791000.00
SKIN income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -1801000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 10947000.00
SKIN income_statement (quarterly, 2026-03-31) — Total Unusual Items: -1196000.00
SKIN income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -1196000.00
SKIN balance_sheet (quarterly, 2026-03-31) — Working Capital: 122493000.00
SKIPPER.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -3305610000.00
SKIPPER.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 1174740000.00
SKIPPER.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -32150000.00
SKIPPER.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 2770000.00
SKIPPER.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 2363140000.00
SKIPPER.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 11170000.00
SKIPPER.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 170000.00
SKIPPER.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 3220930000.00
SKIPPER.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 91560000.00
SKIPPER.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 4376120000.00
SKIPPER.NS balance_sheet (annual, 2022-03-31) — Hedging Assets Current: 35380000.00
SKIPPER.NS income_statement (annual, 2022-03-31) — Interest Income: 16350000.00
SKIPPER.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 16350000.00
SKIPPER.NS balance_sheet (annual, 2022-03-31) — Investmentsin Joint Venturesat Cost: 72180000.00
SKIPPER.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 1543690000.00
SKIPPER.NS balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 72180000.00
SKIPPER.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 5960720000.00
SKIPPER.NS cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: -9630000.00
SKIPPER.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 60410000.00
SKIPPER.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 174970000.00
SKIPPER.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 104600000.00
SKIPPER.NS balance_sheet (annual, 2022-03-31) — Other Payable: 189650000.00
SKIPPER.NS income_statement (annual, 2022-03-31) — Other Special Charges: -3340000.00
SKIPPER.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 11760000.00
SKIPPER.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 934190000.00
SKIPPER.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
SKIPPER.NS cash_flow (annual, 2022-03-31) — Purchase Of Business: -9630000.00
SKIPPER.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 3848640000.00
SKIPPER.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 38410000.00
SKIPPER.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 38410000.00
SKIPPER.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 380860000.00
SKIPPER.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 5604140000.00
SKIPPER.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 580800000.00
SKIPPER.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 672360000.00
SKIPPER.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 126720000.00
SKIPPER.NS balance_sheet (annual, 2022-03-31) — Work In Process: 686470000.00
SKIPPER.NS income_statement (annual, 2022-03-31) — Write Off: 2530000.00
SKIPPER.NS income_statement (annual, 2023-03-31) — +Operating Expense: 3748070000.00
SKIPPER.NS income_statement (annual, 2023-03-31) — +Total Revenue: 19620460000.00
SKIPPER.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 5881150000.00
SKIPPER.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 3602220000.00
SKIPPER.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -3738820000.00
SKIPPER.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 1174740000.00
SKIPPER.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -22600000.00
SKIPPER.NS income_statement (annual, 2023-03-31) — Amortization: 4680000.00